Gabapentin successfully manages chronic unexplained irritability in children with severe neurologic impairment

被引:50
作者
Hauer, Julie M.
Wical, Beverly S.
Charnas, Lawrence
机构
[1] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Div Pediat Clin Neurosci, Minneapolis, MN 55455 USA
[3] Gillette Childrens Specialty Healthcare, St Paul, MN USA
关键词
irritability; pain; visceral hyperalgesia; gabapentin; neurological impairment;
D O I
10.1542/peds.2006-1609
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Neurologically impaired children have an increased frequency of recurrent pain and irritability that persist in some despite comprehensive evaluation and management of possible pain sources. We hypothesized that visceral hyperalgesia was a source of chronic unexplained irritability and report the outcome of gabapentin treatment in 9 severely neurologically impaired children. Caregivers reported marked improvement after treatment ranging from 3 months to 3 years. Nystagmus in 1 child was the only noted adverse effect. Visceral hyperalgesia may be a source of unexplained irritability in the neurologically impaired child. Symptoms may improve with gabapentin treatment.
引用
收藏
页码:E519 / E522
页数:4
相关论文
共 25 条
[1]   A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development [J].
Al-Chaer, ED ;
Kawasaki, M ;
Pasricha, PJ .
GASTROENTEROLOGY, 2000, 119 (05) :1276-1285
[2]   Inflammation-induced hyperexcitability of nociceptive gastrointestinal DRG neurones: the role of voltage-gated ion channels [J].
Beyak, MJ ;
Vanner, S .
NEUROGASTROENTEROLOGY AND MOTILITY, 2005, 17 (02) :175-186
[3]   Risk factors for pain in children with severe cognitive impairments [J].
Breau, LM ;
Camfield, CS ;
McGrath, PJ ;
Finley, GA .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2004, 46 (06) :364-371
[4]   The incidence of pain in children with severe cognitive impairments [J].
Breau, LM ;
Camfield, CS ;
McGrath, PJ ;
Finley, GA .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2003, 157 (12) :1219-1226
[5]   Pathobiology of visceral pain:: Molecular mechanisms and therapeutic implications III.: Visceral afferent pathways:: a source of new therapeutic targets for abdominal pain [J].
Buéno, L ;
Fioramonti, J ;
Garcia-Villar, R .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2000, 278 (05) :G670-G676
[6]   Putative therapeutic targets in the treatment of visceral hyperalgesia [J].
Collins, S .
GUT, 2004, 53 :19-21
[7]   Gastrointestinal manifestations in children with cerebral palsy [J].
Del Giudice, E ;
Staiano, A ;
Capano, G ;
Romano, A ;
Florimonte, L ;
Miele, E ;
Ciarla, C ;
Campanozzi, A ;
Crisanti, AF .
BRAIN & DEVELOPMENT, 1999, 21 (05) :307-311
[8]   Interactive involvement of brain derived neurotrophic factor, nerve growth factor, and calcitonin gene related peptide in colonic hypersensitivity in the rat [J].
Delafoy, L. ;
Gelot, A. ;
D Ardid ;
Eschalier, A. ;
Bertrand, C. ;
Doherty, A. M. ;
Diop, L. .
GUT, 2006, 55 (07) :940-945
[9]   Visceral hypersensitivity [J].
Delgado-Aros, S ;
Camilleri, M .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2005, 39 (04) :S194-S203
[10]   Visceral hyperalgesia in children with functional abdominal pain [J].
Di Lorenzo, C ;
Youssef, NN ;
Sigurdsson, L ;
Scharff, L ;
Griffiths, J ;
Wald, A .
JOURNAL OF PEDIATRICS, 2001, 139 (06) :838-843